Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetics of Elexacaftor/Tezacaftor/Ivacaftor in Cystic Fibrosis
NCT07809867Phase 4Recruiting
- Sponsor
- Istituto Giannina Gaslini
- Start
- Sep 2026
- Primary completion
- Apr 2028
- Countries
- 1
01
Overview
A Phase 4 trial of elexacaftor, tezacaftor, ivacaftor in cystic fibrosis (CF), sponsored by Istituto Giannina Gaslini. Started Sep 2026; status: recruiting.
02
Drugs
elexacaftortezacaftorivacaftor
03
Conditions
cystic fibrosis (CF)
Beyond the preview
Go deeper on NCT07809867.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07809867.